Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Males
NCT02233218Phase 1Completed
- Sponsor
- Yuhan
- Start
- Jul 2014
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of telmisartan, amlodipine and rosuvastatin in hypertension (HTN) and dyslipidemia (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma concentration-time curve in steady-state at Day 14 and Maximum concentration in steady-state at Day 14. Started Jul 2014; status: completed.
02
Drugs
telmisartanamlodipinerosuvastatin
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT02233218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233218.